Acadia Pharmaceuticals reported $130.71M in Sales Revenues for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acadia Pharmaceuticals ACAD:US USD 130.71M 3.85M
ALKERMES ALKS:US USD 252.36M 23.86M
Alnylam Pharmaceuticals ALNY:US USD 264.31M 39.49M
Biogen BIIB:US USD 2.51B 80.6M
Biomarin Pharmaceutical BMRN:US USD 505.34M 28.45M
Bristol Myers Squibb BMY:US USD 11.22B 669M
Cara Therapeutics CARA:US USD 10.81M 12.19M
Corcept Therapeutics CORT:US USD 101.73M 1.66M
Cytokinetics CYTK:US USD 2.51M 86.45M
Eisai 4523:JP JPY 174.36B 9.9B
Eli Lilly And LLY:US USD 6.94B 453.6M
Intercept Pharmaceuticals ICPT:US USD 77.59M 5.83M
Intra Cellular Therapies ITCI:US USD 71.87M 16.29M
Johnson & Johnson JNJ:US USD 23.71B 85M
Marinus Pharmaceuticals MRNS:US USD 2.34M 550K
Moderna Inc MRNA:US USD 3.36B 1.38B
Neurocrine Biosciences NBIX:US USD 387.9M 9.7M
Pfizer PFE:US USD 22.64B 5.1B
Prothena PRTA:US USD 1.52M 205K
Ptc Therapeutics PTCT:US USD 217.13M 51.6M
Sarepta Therapeutics SRPT:US USD 230.27M 3.22M
Seattle Genetics SGEN:US USD 510.3M 12.8M
Ultragenyx Pharmaceutical RARE:US USD 90.7M 1.36M
Vanda Pharmaceuticals VNDA:US USD 130.64M 1.86M
Vertex Pharmaceuticals VRTX:US USD 2.33B 138.1M
YTE INCY:US USD 823.3M 88.09M